Sterol regulatory element-binding transcription factor 1 (SREBF1) also known as sterol regulatory element-binding protein 1 (SREBP-1) is a protein that in humans is encoded by the SREBF1 gene.[5][6]
This gene is located within the Smith–Magenis syndrome region on chromosome 17. Two transcript variants encoding different isoforms have been found for this gene.[7] The isoforms are SREBP-1a and SREBP-1c (the latter also called ADD-1). SREBP-1a is expressed in the intestine and spleen, whereas SREBP-1c is mainly expressed in liver, muscle, and fat (among other tissues).[citation needed]
Expression
editThe proteins encoded by this gene are transcription factors that bind to a sequence in the promoter of different genes, called sterol regulatory element-1 (SRE1). This element is a decamer (oligomer with ten subunits) flanking the LDL receptor gene and other genes involved in, for instance, sterol biosynthesis. The protein is synthesized as a precursor that is attached to the nuclear membrane and endoplasmic reticulum. Following cleavage, the mature protein translocates to the nucleus and activates transcription by binding to the SRE1. Sterols inhibit the cleavage of the precursor, and the mature nuclear form is rapidly catabolized, thereby reducing transcription. The protein is a member of the basic helix-loop-helix-leucine zipper (bHLH-Zip) transcription factor family.
SREBP-1a regulates genes related to lipid and cholesterol production and its activity is regulated by sterol levels in the cell.[8]
SREBP-1a and SREBP-1c are both encoded by the same gene, but are transcribed by different promoters.[9] For animals in a fasted state, SREBP-1c expression is suppressed in the liver, but a high carbohydrate meal (by insulin release) strongly induces SREBP-1c expression.[9]
Function
editSREBP-1 plays a key role in the induction of lipogenesis by the liver.[10] mTORC1 is activated by insulin (a hormone of nutrient abundance) leading to increased production of SREBP-1c, which facilitates storage of fatty acids (excess nutrients) as triglycerides.[11]
Clinical relevance
editSREBP-1c regulates genes required for glucose metabolism and fatty acid and lipid production and its expression is induced by insulin.[12] Insulin-stimulated SREBP-1c increases glycolysis by activation of glucokinase enzyme, and increases lipogenesis (conversion of carbohydrates into fatty acids).[12] Insulin stimulation of SREBP-1c is mediated by liver X receptor (LXR) and mTORC1.[13]
High blood levels of insulin due to insulin resistance often leads to steatosis in the liver because of SREBP-1 activation.[9] Suppression of SREBP-1c by sirtuin 1[14] or by other means[15] protects against development of fatty liver.
SREBP-1 is highly activated in cancers because tumor cells require lipids for cell membranes, second messengers, and energy.[16][17]
Interactions
editSREBF1 has been shown to interact with:
See also
editReferences
edit- ^ a b c GRCh38: Ensembl release 89: ENSG00000072310 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000020538 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, et al. (October 1993). "SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene". Cell. 75 (1): 187–197. doi:10.1016/S0092-8674(05)80095-9. PMID 8402897. S2CID 2784016.
- ^ Hua X, Wu J, Goldstein JL, Brown MS, Hobbs HH (February 1995). "Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13". Genomics. 25 (3): 667–673. doi:10.1016/0888-7543(95)80009-B. PMID 7759101.
- ^ "Entrez Gene: SREBF1 sterol regulatory element binding transcription factor 1".
- ^ Eberlé D, Hegarty B, Bossard P, Ferré P, Foufelle F (November 2004). "SREBP transcription factors: master regulators of lipid homeostasis". Biochimie. 86 (11): 839–848. doi:10.1016/j.biochi.2004.09.018. PMID 15589694.
- ^ a b c Xu X, So JS, Park JG, Lee AH (November 2013). "Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP". Seminars in Liver Disease. 33 (4): 301–311. doi:10.1055/s-0033-1358523. PMC 4035704. PMID 24222088.
- ^ Shimano H, Yahagi N, Amemiya-Kudo M, Hasty AH, Osuga J, Tamura Y, et al. (December 1999). "Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes". The Journal of Biological Chemistry. 274 (50): 35832–35839. doi:10.21037/hbsn.2016.11.08. PMC 5218901. PMID 10585467.
- ^ Li S, Brown MS, Goldstein JL (February 2010). "Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis". Proceedings of the National Academy of Sciences of the United States of America. 107 (8): 3441–3446. Bibcode:2010PNAS..107.3441L. doi:10.1073/pnas.0914798107. PMC 2840492. PMID 20133650.
- ^ a b Ferré P, Foufelle F (October 2010). "Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c". Diabetes, Obesity & Metabolism. 12 Suppl 2 (Suppl 2): 83–92. doi:10.1111/j.1463-1326.2010.01275.x. PMID 21029304. S2CID 23614683.
- ^ Bakan I, Laplante M (June 2012). "Connecting mTORC1 signaling to SREBP-1 activation". Current Opinion in Lipidology. 23 (3): 226–234. doi:10.1097/MOL.0b013e328352dd03. PMID 22449814. S2CID 19390378.
- ^ Ponugoti B, Kim DH, Xiao Z, Smith Z, Miao J, Zang M, et al. (October 2010). "SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism". The Journal of Biological Chemistry. 285 (44): 33959–33970. doi:10.1074/jbc.M110.122978. PMC 2962496. PMID 20817729.
- ^ Song Z, Xiaoli AM, Yang F (September 2018). "Regulation and Metabolic Significance of De Novo Lipogenesis in Adipose Tissues". Nutrients. 10 (10): E1383. doi:10.3390/nu10101383. PMC 6213738. PMID 30274245.
- ^ Guo D, Bell EH, Mischel P, Chakravarti A (2014). "Targeting SREBP-1-driven lipid metabolism to treat cancer". Current Pharmaceutical Design. 20 (15): 2619–2626. doi:10.2174/13816128113199990486. PMC 4148912. PMID 23859617.
- ^ Ezzeddini R, Taghikhani M, Somi MH, Samadi N, Rasaee MJ (May 2019). "Clinical importance of FASN in relation to HIF-1α and SREBP-1c in gastric adenocarcinoma". Life Sciences. 224: 169–176. doi:10.1016/j.lfs.2019.03.056. PMID 30914315. S2CID 85532042.
- ^ Oliner JD, Andresen JM, Hansen SK, Zhou S, Tjian R (November 1996). "SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein". Genes & Development. 10 (22): 2903–2911. doi:10.1101/gad.10.22.2903. PMID 8918891.
- ^ Lopez D, Shea-Eaton W, Sanchez MD, McLean MP (December 2001). "DAX-1 represses the high-density lipoprotein receptor through interaction with positive regulators sterol regulatory element-binding protein-1a and steroidogenic factor-1". Endocrinology. 142 (12): 5097–5106. doi:10.1210/endo.142.12.8523. PMID 11713202.
- ^ Lloyd DJ, Trembath RC, Shackleton S (April 2002). "A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies". Human Molecular Genetics. 11 (7): 769–777. doi:10.1093/hmg/11.7.769. PMID 11929849.
- ^ Lee YS, Lee HH, Park J, Yoo EJ, Glackin CA, Choi YI, et al. (December 2003). "Twist2, a novel ADD1/SREBP1c interacting protein, represses the transcriptional activity of ADD1/SREBP1c". Nucleic Acids Research. 31 (24): 7165–7174. doi:10.1093/nar/gkg934. PMC 291873. PMID 14654692.
- ^ a b Gorski JP, Price JL (2016). "Bone muscle crosstalk targets muscle regeneration pathway regulated by core circadian transcriptional repressors DEC1 and DEC2". BoneKEy Reports. 5: 850. doi:10.1038/bonekey.2016.80. PMC 5111231. PMID 27867498.
Further reading
edit- Osborne TF (August 2001). "CREating a SCAP-less liver keeps SREBPs pinned in the ER membrane and prevents increased lipid synthesis in response to low cholesterol and high insulin". Genes & Development. 15 (15): 1873–1878. doi:10.1101/gad.916601. PMID 11485982.
- Kotzka J, Müller-Wieland D (April 2004). "Sterol regulatory element-binding protein (SREBP)-1: gene regulatory target for insulin resistance?". Expert Opinion on Therapeutic Targets. 8 (2): 141–149. doi:10.1517/14728222.8.2.141. PMID 15102555. S2CID 34317215.
- Szolkiewicz M, Chmielewski M, Nogalska A, Stelmanska E, Swierczynski J, Rutkowski B (January 2007). "The potential role of sterol regulatory element binding protein transcription factors in renal injury". Journal of Renal Nutrition. 17 (1): 62–65. doi:10.1053/j.jrn.2006.10.009. PMID 17198935.
- Ferré P, Foufelle F (2007). "SREBP-1c transcription factor and lipid homeostasis: clinical perspective". Hormone Research. 68 (2): 72–82. doi:10.1159/000100426 (inactive 23 December 2024). PMID 17344645.
{{cite journal}}
: CS1 maint: DOI inactive as of December 2024 (link) - Hua X, Yokoyama C, Wu J, Briggs MR, Brown MS, Goldstein JL, et al. (December 1993). "SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element". Proceedings of the National Academy of Sciences of the United States of America. 90 (24): 11603–11607. Bibcode:1993PNAS...9011603H. doi:10.1073/pnas.90.24.11603. PMC 48032. PMID 7903453.
- Sato R, Yang J, Wang X, Evans MJ, Ho YK, Goldstein JL, et al. (June 1994). "Assignment of the membrane attachment, DNA binding, and transcriptional activation domains of sterol regulatory element-binding protein-1 (SREBP-1)". The Journal of Biological Chemistry. 269 (25): 17267–17273. doi:10.1016/S0021-9258(17)32550-4. PMID 8006035.
- Wang X, Sato R, Brown MS, Hua X, Goldstein JL (April 1994). "SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis". Cell. 77 (1): 53–62. doi:10.1016/0092-8674(94)90234-8. PMID 8156598. S2CID 44899129.
- Wang X, Briggs MR, Hua X, Yokoyama C, Goldstein JL, Brown MS (July 1993). "Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. II. Purification and characterization". The Journal of Biological Chemistry. 268 (19): 14497–14504. doi:10.1016/S0021-9258(19)85266-3. PMID 8314806.
- Hua X, Sakai J, Brown MS, Goldstein JL (April 1996). "Regulated cleavage of sterol regulatory element binding proteins requires sequences on both sides of the endoplasmic reticulum membrane". The Journal of Biological Chemistry. 271 (17): 10379–10384. doi:10.1074/jbc.271.17.10379. PMID 8626610.
- Shimomura I, Shimano H, Horton JD, Goldstein JL, Brown MS (March 1997). "Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells". The Journal of Clinical Investigation. 99 (5): 838–845. doi:10.1172/JCI119247. PMC 507890. PMID 9062340.
- Miserez AR, Cao G, Probst LC, Hobbs HH (February 1997). "Structure of the human gene encoding sterol regulatory element binding protein 2 (SREBF2)". Genomics. 40 (1): 31–40. doi:10.1006/geno.1996.4525. PMID 9070916.
- Párraga A, Bellsolell L, Ferré-D'Amaré AR, Burley SK (May 1998). "Co-crystal structure of sterol regulatory element binding protein 1a at 2.3 A resolution". Structure. 6 (5): 661–672. doi:10.1016/S0969-2126(98)00067-7. PMID 9634703.
- Ericsson J, Edwards PA (July 1998). "CBP is required for sterol-regulated and sterol regulatory element-binding protein-regulated transcription". The Journal of Biological Chemistry. 273 (28): 17865–17870. doi:10.1074/jbc.273.28.17865. PMID 9651391.
- Bennett MK, Ngo TT, Athanikar JN, Rosenfeld JM, Osborne TF (May 1999). "Co-stimulation of promoter for low density lipoprotein receptor gene by sterol regulatory element-binding protein and Sp1 is specifically disrupted by the yin yang 1 protein". The Journal of Biological Chemistry. 274 (19): 13025–13032. doi:10.1074/jbc.274.19.13025. PMID 10224053.
- Moldes M, Boizard M, Liepvre XL, Fève B, Dugail I, Pairault J (December 1999). "Functional antagonism between inhibitor of DNA binding (Id) and adipocyte determination and differentiation factor 1/sterol regulatory element-binding protein-1c (ADD1/SREBP-1c) trans-factors for the regulation of fatty acid synthase promoter in adipocytes". The Biochemical Journal. 344 Pt 3 (Pt 3): 873–880. doi:10.1042/0264-6021:3440873. PMC 1220711. PMID 10585876.
- DeBose-Boyd RA, Brown MS, Li WP, Nohturfft A, Goldstein JL, Espenshade PJ (December 1999). "Transport-dependent proteolysis of SREBP: relocation of site-1 protease from Golgi to ER obviates the need for SREBP transport to Golgi". Cell. 99 (7): 703–712. doi:10.1016/S0092-8674(00)81668-2. PMID 10619424.
- Roth G, Kotzka J, Kremer L, Lehr S, Lohaus C, Meyer HE, et al. (October 2000). "MAP kinases Erk1/2 phosphorylate sterol regulatory element-binding protein (SREBP)-1a at serine 117 in vitro". The Journal of Biological Chemistry. 275 (43): 33302–33307. doi:10.1074/jbc.M005425200. PMID 10915800.
- Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, Goldstein JL (July 2000). "Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice". Molecular Cell. 6 (1): 77–86. doi:10.1016/S1097-2765(00)00009-5. PMID 10949029.
External links
edit- SREBF1+protein,+human at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- FactorBook SREBP1
This article incorporates text from the United States National Library of Medicine, which is in the public domain.